FDA Import Refusal AEK-0725103-5/10002/1 — NOVO NORDISK

NOVO NORDISK — FEI 3014158939

The FDA refused shipment AEK-0725103-5/10002/1 from NOVO NORDISK (Canada) on July 10, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
July 10, 2026
Country
Canada
Product Category
Drugs and Biologics
Product Code
61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)
Charges
75